CETIRIZINE HYDROCHLORIDE TABLETS

CETIRIZINE HYDROCHLORIDE TABLETS was reported 31379 times

These side effects are most commonly reported by patients taking CETIRIZINE HYDROCHLORIDE TABLETS:

# Side effect Count
0 DRUG INEFFECTIVE 9563
1 PAIN 8981
2 FATIGUE 8943
3 ALOPECIA 7541
4 RHEUMATOID ARTHRITIS 7475
5 ABDOMINAL DISCOMFORT 7448
6 SYSTEMIC LUPUS ERYTHEMATOSUS 7162
7 PEMPHIGUS 7032
8 OFF LABEL USE 6778
9 RASH 6690
10 GLOSSODYNIA 6533
11 SWELLING 6090
12 HYPERSENSITIVITY 5814
13 HAND DEFORMITY 5687
14 INFUSION RELATED REACTION 5618
15 ARTHROPATHY 5576
16 CONTRAINDICATED PRODUCT ADMINISTERED 5558
17 WOUND 5477
18 JOINT SWELLING 5275
19 DRUG INTOLERANCE 5088
20 HEADACHE 5046
21 ARTHRALGIA 4970
22 PERICARDITIS 4966
23 HEPATIC ENZYME INCREASED 4949
24 MATERNAL EXPOSURE DURING PREGNANCY 4864
25 SYNOVITIS 4842
26 DISCOMFORT 4722
27 PRODUCT USE ISSUE 4693
28 PRURITUS 4377
29 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4239
30 CONDITION AGGRAVATED 4203
31 NAUSEA 3980
32 DYSPNOEA 3925
33 PYREXIA 3817
34 URTICARIA 3715
35 DUODENAL ULCER PERFORATION 3712
36 HELICOBACTER INFECTION 3663
37 HYPERTENSION 3649
38 TREATMENT FAILURE 3603
39 DIARRHOEA 3499
40 MALAISE 3485
41 GENERAL PHYSICAL HEALTH DETERIORATION 3474
42 VOMITING 3362
43 BLISTER 3205
44 DIZZINESS 3204
45 WEIGHT INCREASED 3203
46 THERAPEUTIC PRODUCT EFFECT DECREASED 3178
47 NASOPHARYNGITIS 3163
48 INFECTION 3129
49 PERIPHERAL SWELLING 3092
50 RHEUMATOID FACTOR POSITIVE 3057
51 TYPE 2 DIABETES MELLITUS 2973
52 DRUG HYPERSENSITIVITY 2972
53 PSORIATIC ARTHROPATHY 2967
54 MUSCULOSKELETAL STIFFNESS 2964
55 CONFUSIONAL STATE 2844
56 LOWER RESPIRATORY TRACT INFECTION 2827
57 FOLLICULITIS 2825
58 IMPAIRED HEALING 2778
59 INTENTIONAL PRODUCT USE ISSUE 2763
60 IRRITABLE BOWEL SYNDROME 2731
61 SINUSITIS 2717
62 BLOOD CHOLESTEROL INCREASED 2708
63 HYPOAESTHESIA 2708
64 STOMATITIS 2707
65 ABDOMINAL PAIN UPPER 2655
66 RHEUMATIC FEVER 2630
67 MOBILITY DECREASED 2594
68 LIVER INJURY 2567
69 FIBROMYALGIA 2472
70 MUSCLE INJURY 2459
71 GASTROINTESTINAL DISORDER 2424
72 INJURY 2420
73 INSOMNIA 2413
74 WHEEZING 2342
75 PRODUCT USE IN UNAPPROVED INDICATION 2333
76 ASTHMA 2327
77 EXPOSURE DURING PREGNANCY 2307
78 ILL-DEFINED DISORDER 2296
79 CONTUSION 2240
80 PNEUMONIA 2208
81 ASTHENIA 2158
82 DECREASED APPETITE 2142
83 SWOLLEN JOINT COUNT INCREASED 2017
84 PAIN IN EXTREMITY 1963
85 SLEEP DISORDER 1906
86 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1897
87 ANXIETY 1858
88 CHEST PAIN 1846
89 MIGRAINE 1846
90 DRY MOUTH 1835
91 WEIGHT DECREASED 1784
92 DEPRESSION 1778
93 MEMORY IMPAIRMENT 1715
94 DYSPEPSIA 1713
95 OEDEMA 1677
96 BURSITIS 1637
97 PRESCRIBED OVERDOSE 1604
98 JOINT RANGE OF MOTION DECREASED 1596
99 OSTEOARTHRITIS 1574
100 INFLAMMATION 1529
101 MUSCULAR WEAKNESS 1520
102 ABDOMINAL PAIN 1513
103 GAIT INABILITY 1497
104 PARAESTHESIA 1489
105 GAIT DISTURBANCE 1468
106 MUSCLE SPASMS 1375
107 LIP DRY 1367
108 NIGHT SWEATS 1363
109 LUNG DISORDER 1322
110 FACET JOINT SYNDROME 1321
111 HYPERCHOLESTEROLAEMIA 1308
112 WOUND INFECTION 1287
113 ADVERSE DRUG REACTION 1286
114 BACK PAIN 1282
115 GRIP STRENGTH DECREASED 1264
116 C-REACTIVE PROTEIN ABNORMAL 1257
117 ROAD TRAFFIC ACCIDENT 1251
118 AMNESIA 1229
119 LIVER DISORDER 1228
120 ADVERSE EVENT 1223
121 C-REACTIVE PROTEIN INCREASED 1210
122 HIP ARTHROPLASTY 1200
123 SCIATICA 1192
124 MUSCULOSKELETAL PAIN 1188
125 OBESITY 1174
126 PULMONARY FIBROSIS 1162
127 AUTOIMMUNE DISORDER 1144
128 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1143
129 KNEE ARTHROPLASTY 1135
130 DEEP VEIN THROMBOSIS POSTOPERATIVE 1125
131 LOWER LIMB FRACTURE 1110
132 COUGH 1108
133 ERYTHEMA 1092
134 BREAST CANCER STAGE III 1082
135 LIVE BIRTH 1061
136 THERAPY NON-RESPONDER 1049
137 HYPERHIDROSIS 1048
138 PERIPHERAL VENOUS DISEASE 1023
139 DELIRIUM 981
140 GASTROOESOPHAGEAL REFLUX DISEASE 978
141 OEDEMA PERIPHERAL 970
142 VISUAL IMPAIRMENT 962
143 FALL 946
144 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 908
145 UPPER RESPIRATORY TRACT INFECTION 907
146 DISLOCATION OF VERTEBRA 898
147 PRESCRIBED UNDERDOSE 896
148 PSORIASIS 879
149 OVERDOSE 846
150 EPILEPSY 844
151 SOMNOLENCE 836
152 COELIAC DISEASE 824
153 COVID-19 805
154 INTENTIONAL PRODUCT MISUSE 783
155 RED BLOOD CELL SEDIMENTATION RATE INCREASED 778
156 ARTHRITIS 776
157 FEELING ABNORMAL 756
158 CONSTIPATION 751
159 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 744
160 TACHYCARDIA 733
161 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 720
162 DRUG-INDUCED LIVER INJURY 713
163 CROHN^S DISEASE 700
164 BLEPHAROSPASM 699
165 IMMUNODEFICIENCY 683
166 ANGIOEDEMA 680
167 LUPUS VULGARIS 680
168 MEDICATION ERROR 680
169 X-RAY ABNORMAL 679
170 FLUID RETENTION 671
171 TASTE DISORDER 667
172 PRODUCT DOSE OMISSION ISSUE 652
173 HEPATIC CIRRHOSIS 649
174 EXOSTOSIS 646
175 EAR INFECTION 645
176 BLOOD PRESSURE INCREASED 631
177 NAIL DISORDER 629
178 BONE EROSION 617
179 HEART RATE INCREASED 608
180 FOOT DEFORMITY 605
181 LARYNGITIS 599
182 MACULAR DEGENERATION 595
183 ABDOMINAL DISTENSION 593
184 JOINT STIFFNESS 593
185 RASH ERYTHEMATOUS 589
186 RETINITIS 580
187 OSTEOPOROSIS 571
188 THROMBOCYTOPENIA 569
189 FOOD ALLERGY 568
190 LUPUS-LIKE SYNDROME 568
191 PALPITATIONS 566
192 LIVER FUNCTION TEST INCREASED 562
193 PRODUCT QUALITY ISSUE 561
194 RESPIRATORY DISORDER 559
195 NECK PAIN 553
196 BRONCHITIS 543
197 PREGNANCY 543
198 UNDERDOSE 538
199 HYPOTENSION 531
200 INJECTION SITE REACTION 520
201 ONYCHOMADESIS 520
202 JOINT DISLOCATION 518
203 EAR PAIN 505
204 THERAPEUTIC RESPONSE DECREASED 501
205 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 496
206 INCORRECT DOSE ADMINISTERED 490
207 ILLNESS 474
208 DRY SKIN 471
209 CHEST DISCOMFORT 470
210 OROPHARYNGEAL PAIN 464
211 FEELING HOT 463
212 C-REACTIVE PROTEIN 456
213 DEATH 443
214 WALKING AID USER 439
215 ANAPHYLACTIC REACTION 437
216 NASAL CONGESTION 434
217 BREAST CANCER STAGE II 433
218 COGNITIVE DISORDER 428
219 BACK INJURY 424
220 ONYCHOMYCOSIS 423
221 COLITIS ULCERATIVE 421
222 INFLUENZA 420
223 DRUG TOLERANCE DECREASED 417
224 DISABILITY 415
225 DISTURBANCE IN ATTENTION 415
226 EYE PRURITUS 409
227 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 404
228 LIP SWELLING 402
229 HEPATITIS 399
230 TEMPERATURE REGULATION DISORDER 398
231 HOSPITALISATION 397
232 FREQUENT BOWEL MOVEMENTS 392
233 DEHYDRATION 391
234 RECTAL HAEMORRHAGE 390
235 DYSPHAGIA 387
236 BLOOD GLUCOSE INCREASED 385
237 URINARY TRACT INFECTION 385
238 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 383
239 HALLUCINATION 373
240 FINGER DEFORMITY 351
241 TINNITUS 349
242 MYOCARDIAL INFARCTION 343
243 LOSS OF CONSCIOUSNESS 329
244 CONGENITAL ANOMALY 326
245 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 325
246 RHINORRHOEA 324
247 FOETAL EXPOSURE DURING PREGNANCY 320
248 PRODUCT LABEL CONFUSION 320
249 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 318
250 STRESS 317
251 PAIN OF SKIN 316
252 MYALGIA 315
253 THROAT IRRITATION 314
254 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 313
255 CHILLS 309
256 INJECTION SITE PAIN 309
257 WHITE BLOOD CELL COUNT INCREASED 308
258 ADVERSE REACTION 301
259 BODY TEMPERATURE INCREASED 300
260 MUSCLE TWITCHING 300
261 PRODUCTIVE COUGH 300
262 SUBARACHNOID HAEMORRHAGE 299
263 BLINDNESS 298
264 ANOSMIA 296
265 MATERNAL EXPOSURE TIMING UNSPECIFIED 295
266 DIPLOPIA 291
267 TRANSIENT ISCHAEMIC ATTACK 288
268 PANCREATITIS 287
269 EXPIRED PRODUCT ADMINISTERED 286
270 VASCULITIS 286
271 ADRENAL INSUFFICIENCY 285
272 SLEEP TERROR 284
273 ULCER HAEMORRHAGE 283
274 SERONEGATIVE ARTHRITIS 282
275 ANAEMIA 280
276 FACIAL PAIN 279
277 SWELLING FACE 277
278 TREMOR 273
279 PRURITUS GENITAL 272
280 TENSION HEADACHE 272
281 OXYGEN SATURATION DECREASED 270
282 NO ADVERSE EVENT 266
283 FOETAL DEATH 264
284 VENTRICULAR TACHYCARDIA 264
285 ATRIAL TACHYCARDIA 263
286 CARDIOSPASM 261
287 RASH PRURITIC 261
288 SYNCOPE 261
289 BLOOD PRESSURE SYSTOLIC INCREASED 260
290 CAROTID ARTERY OCCLUSION 259
291 DRUG INTERACTION 257
292 PALMOPLANTAR KERATODERMA 255
293 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 250
294 DEPRESSED MOOD 247
295 DRUG TOLERANCE 245
296 BALANCE DISORDER 244
297 CHRONIC SINUSITIS 242
298 PORPHYRIA ACUTE 240
299 SEIZURE 236
300 OBSTRUCTIVE AIRWAYS DISORDER 229
301 FLUSHING 227
302 MUSCLE SPASTICITY 227
303 ECZEMA 224
304 HYPOKALAEMIA 220
305 PARAESTHESIA ORAL 218
306 ACUTE KIDNEY INJURY 217
307 NEUROPATHY PERIPHERAL 217
308 DYSPHONIA 216
309 BACK DISORDER 213
310 DRY EYE 208
311 ALANINE AMINOTRANSFERASE INCREASED 205
312 RASH PAPULAR 204
313 MIDDLE INSOMNIA 202
314 SKIN LESION 202
315 RASH VESICULAR 201
316 LEUKOPENIA 193
317 MYOSITIS 193
318 DRUG DEPENDENCE 192
319 PUSTULAR PSORIASIS 190
320 LABORATORY TEST ABNORMAL 189
321 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 189
322 BLOOD PRESSURE DECREASED 186
323 JOINT INJURY 186
324 EYE SWELLING 185
325 LIMB DISCOMFORT 184
326 SPONDYLITIS 182
327 PROCEDURAL PAIN 179
328 JOINT DESTRUCTION 178
329 IMMUNISATION 175
330 HAEMATOCHEZIA 173
331 GENERAL SYMPTOM 169
332 VISION BLURRED 169
333 TEMPERATURE INTOLERANCE 168
334 NORMAL NEWBORN 167
335 EXTRA DOSE ADMINISTERED 166
336 SUICIDAL IDEATION 166
337 PLEURAL EFFUSION 165
338 TOXICITY TO VARIOUS AGENTS 165
339 WHITE BLOOD CELL COUNT DECREASED 164
340 MULTIPLE SCLEROSIS 163
341 POLYARTHRITIS 161
342 ULCER 160
343 BLOOD PRESSURE FLUCTUATION 159
344 INFUSION SITE REACTION 159
345 WEIGHT FLUCTUATION 159
346 ASPARTATE AMINOTRANSFERASE INCREASED 158
347 CHRONIC KIDNEY DISEASE 157
348 EYE INJURY 157
349 DRUG ABUSE 151
350 GASTROENTERITIS VIRAL 151
351 INJECTION SITE ERYTHEMA 148
352 NEUTROPENIA 148
353 VERTIGO 148
354 HERPES ZOSTER 146
355 THERAPEUTIC RESPONSE SHORTENED 143
356 DIABETES MELLITUS 142
357 DRUG USE DISORDER 142
358 HEART RATE DECREASED 142
359 DEATH NEONATAL 139
360 FEBRILE NEUTROPENIA 139
361 INFLUENZA LIKE ILLNESS 138
362 BURNING SENSATION 137
363 COORDINATION ABNORMAL 137
364 SCRATCH 137
365 SEASONAL ALLERGY 137
366 SINUS DISORDER 136
367 AGITATION 135
368 HOT FLUSH 134
369 RENAL FAILURE 134
370 SKIN PLAQUE 133
371 ACCIDENTAL OVERDOSE 132
372 EMOTIONAL DISTRESS 131
373 SEPTIC SHOCK 131
374 VIRAL INFECTION 131
375 POST-TRAUMATIC STRESS DISORDER 130
376 DERMATITIS ATOPIC 129
377 TREATMENT NONCOMPLIANCE 129
378 PLATELET COUNT DECREASED 127
379 SWOLLEN JOINT COUNT 126
380 WITHDRAWAL SYNDROME 126
381 DYSPNOEA EXERTIONAL 125
382 EPISTAXIS 125
383 CHRONIC SPONTANEOUS URTICARIA 124
384 ORAL CANDIDIASIS 124
385 BLOOD CREATININE INCREASED 123
386 CATARACT 123
387 HYPONATRAEMIA 123
388 LYMPHOCYTE COUNT DECREASED 123
389 RASH MACULAR 123
390 HAEMOGLOBIN DECREASED 122
391 COLITIS 121
392 EOSINOPHILIA 121
393 INCORRECT PRODUCT ADMINISTRATION DURATION 121
394 SPINAL FUSION SURGERY 121
395 SWOLLEN TONGUE 121
396 NODULE 120
397 BLOOD PRESSURE DIASTOLIC DECREASED 119
398 SKIN EXFOLIATION 119
399 INJECTION SITE SWELLING 118
400 SNEEZING 118
401 RESPIRATORY TRACT INFECTION 117
402 GRIP STRENGTH 115
403 LACRIMATION INCREASED 114
404 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 113
405 VAGINAL DISCHARGE 113
406 EYE PAIN 111
407 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 111
408 THROAT TIGHTNESS 111
409 ELECTRIC SHOCK 110
410 SUICIDE ATTEMPT 110
411 EYE DISORDER 108
412 INTERVERTEBRAL DISCITIS 108
413 CEREBROVASCULAR ACCIDENT 106
414 DEMYELINATION 106
415 INJECTION SITE PRURITUS 105
416 LETHARGY 105
417 RETCHING 105
418 ANAPHYLACTIC SHOCK 104
419 BLOOD IMMUNOGLOBULIN E INCREASED 104
420 HYPOCALCAEMIA 104
421 BONE PAIN 103
422 DYSGEUSIA 103
423 EYE IRRITATION 103
424 SPEECH DISORDER 102
425 OCULAR HYPERAEMIA 101
426 ANTICIPATORY ANXIETY 98
427 FEMALE GENITAL TRACT FISTULA 98
428 RED BLOOD CELL COUNT DECREASED 98
429 RADICULOPATHY 97
430 CYTOKINE RELEASE SYNDROME 96
431 INJECTION SITE BRUISING 96
432 IRRITABILITY 96
433 LIMB INJURY 95
434 PROCTITIS 95
435 BODY TEMPERATURE DECREASED 94
436 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94
437 MOVEMENT DISORDER 92
438 NERVOUSNESS 92
439 DECREASED IMMUNE RESPONSIVENESS 91
440 SLEEP APNOEA SYNDROME 91
441 SPUTUM DISCOLOURED 91
442 FEELING COLD 90
443 FORCED EXPIRATORY VOLUME DECREASED 90
444 BLOOD TEST ABNORMAL 89
445 PHARYNGITIS 89
446 SKIN DISCOLOURATION 89
447 VAGINAL FLATULENCE 89
448 ABORTION SPONTANEOUS 88
449 CELLULITIS 88
450 ACNE 87
451 HEPATIC ENZYME 87
452 POOR QUALITY SLEEP 87
453 ATRIAL FIBRILLATION 85
454 INTENTIONAL OVERDOSE 85
455 THERAPY PARTIAL RESPONDER 85
456 MONOCYTE COUNT INCREASED 84
457 RENAL IMPAIRMENT 84
458 BRADYCARDIA 83
459 NEUTROPHIL COUNT INCREASED 83
460 DRUG EXPOSURE DURING PREGNANCY 82
461 DYSARTHRIA 82
462 HYPERSOMNIA 82
463 SINUS CONGESTION 82
464 SPINAL DISORDER 82
465 BLOOD ALKALINE PHOSPHATASE INCREASED 81
466 VITAMIN D DEFICIENCY 80
467 WHITE BLOOD CELLS URINE POSITIVE 80
468 BLOOD GLUCOSE DECREASED 79
469 CARDIAC DISORDER 79
470 DRUG EFFECT LESS THAN EXPECTED 79
471 CARDIAC FAILURE 78
472 CYSTITIS 78
473 DYSURIA 78
474 HAEMORRHAGE 78
475 NIGHTMARE 78
476 RHINITIS 78
477 SEPSIS 78
478 SKIN REACTION 78
479 APHONIA 77
480 PANIC ATTACK 77
481 SKIN BURNING SENSATION 77
482 THROAT CLEARING 77
483 CONJUNCTIVITIS 76
484 DISEASE RECURRENCE 76
485 POLLAKIURIA 76
486 RASH MACULO-PAPULAR 76
487 AGGRESSION 75
488 FULL BLOOD COUNT ABNORMAL 75
489 FUNGAL INFECTION 75
490 PULMONARY EMBOLISM 75
491 SENSITIVITY TO WEATHER CHANGE 75
492 SKIN DISORDER 75
493 GASTROENTERITIS 74
494 LYMPHADENOPATHY 74
495 RESTLESSNESS 74
496 SECRETION DISCHARGE 74
497 DRUG EFFECT DECREASED 73
498 THERAPEUTIC RESPONSE UNEXPECTED 73
499 INFUSION SITE PAIN 72
500 COMA 71
501 NEPHROLITHIASIS 71
502 PHARYNGEAL SWELLING 71
503 PRODUCT AVAILABILITY ISSUE 71
504 SUSPECTED OFF LABEL USE 70
505 CARDIAC ARREST 69
506 BLOOD UREA INCREASED 68
507 BLOOD URINE PRESENT 68
508 FACE OEDEMA 68
509 BRAIN FOG 67
510 MATERNAL EXPOSURE BEFORE PREGNANCY 67
511 PNEUMONITIS 67
512 URINARY RETENTION 67
513 VITAMIN B12 DEFICIENCY 67
514 ACCIDENTAL EXPOSURE TO PRODUCT 66
515 AGEUSIA 66
516 CRYING 66
517 NEURALGIA 66
518 FLATULENCE 65
519 PAPULE 65
520 PHOTOSENSITIVITY REACTION 65
521 SYMPTOM RECURRENCE 65
522 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 64
523 INTENTIONAL DOSE OMISSION 64
524 ANGER 63
525 DIVERTICULITIS 63
526 GLYCOSYLATED HAEMOGLOBIN INCREASED 63
527 HYPERTRANSAMINASAEMIA 63
528 MUSCULOSKELETAL DISCOMFORT 63
529 ORAL HERPES 63
530 RESPIRATORY TRACT CONGESTION 63
531 BLOOD PRESSURE DIASTOLIC INCREASED 62
532 CARDIAC FAILURE CONGESTIVE 62
533 HAEMORRHOIDS 62
534 HEART RATE IRREGULAR 62
535 HYPOCHOLESTEROLAEMIA 62
536 HYPOGLYCAEMIA 62
537 MIOSIS 62
538 SKIN HAEMORRHAGE 62
539 THROMBOSIS 62
540 FEELING JITTERY 61
541 INTERVERTEBRAL DISC PROTRUSION 61
542 RESTLESS LEGS SYNDROME 61
543 THERAPY INTERRUPTED 61
544 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 60
545 INJECTION SITE HAEMORRHAGE 60
546 OROPHARYNGEAL DISCOMFORT 60
547 PRESYNCOPE 60
548 BRONCHOSPASM 59
549 JOINT EFFUSION 59
550 LARYNGEAL STENOSIS 59
551 SARS-COV-2 TEST POSITIVE 59
552 HEAD DISCOMFORT 58
553 MENTAL DISORDER 58
554 RENAL DISORDER 58
555 ACCIDENT 57
556 EOSINOPHIL COUNT INCREASED 57
557 HEAD INJURY 57
558 SKIN IRRITATION 57
559 BLOOD POTASSIUM DECREASED 56
560 BLOOD PRESSURE DIASTOLIC ABNORMAL 56
561 COMPLETED SUICIDE 56
562 HAEMATOCRIT DECREASED 56
563 OVERLAP SYNDROME 56
564 PRODUCT DOSE OMISSION IN ERROR 56
565 URINE ABNORMALITY 56
566 ARTHROPOD BITE 55
567 BLOOD PRESSURE SYSTOLIC DECREASED 55
568 MULTIPLE SCLEROSIS RELAPSE 55
569 NEUTROPHIL COUNT DECREASED 55
570 ANKLE FRACTURE 54
571 BLOOD URIC ACID INCREASED 54
572 CHOKING 54
573 DERMATITIS CONTACT 54
574 DRUG WITHDRAWAL SYNDROME 54
575 FOOT FRACTURE 54
576 RESPIRATORY FAILURE 54
577 VOCAL CORD DYSFUNCTION 54
578 DACTYLITIS 53
579 FOOT OPERATION 53
580 HYPOXIA 53
581 PRODUCT ADMINISTRATION INTERRUPTED 53
582 SURGERY 53
583 URINARY INCONTINENCE 53
584 CHOLECYSTITIS ACUTE 52
585 HAEMOPTYSIS 52
586 MULTIPLE ALLERGIES 52
587 PRODUCT SUBSTITUTION ISSUE 52
588 GINGIVAL BLEEDING 51
589 HYPOTHYROIDISM 51
590 INTERSTITIAL LUNG DISEASE 51
591 INTESTINAL OBSTRUCTION 51
592 KIDNEY INFECTION 51
593 PERIORBITAL SWELLING 51
594 DISORIENTATION 50
595 GLOMERULAR FILTRATION RATE INCREASED 50
596 GRANULOCYTE COUNT INCREASED 50
597 MOOD ALTERED 50
598 MUSCLE TIGHTNESS 50
599 POOR VENOUS ACCESS 50
600 PRURITUS GENERALISED 50
601 RHEUMATOID FACTOR INCREASED 50
602 RHINITIS ALLERGIC 50
603 WHEELCHAIR USER 50
604 ASPIRATION 49
605 BLOOD IMMUNOGLOBULIN A INCREASED 49
606 DRUG EFFECT INCOMPLETE 49
607 JOINT NOISE 49
608 NAIL OPERATION 49
609 POST CHOLECYSTECTOMY SYNDROME 49
610 SEDATION 49
611 WRONG PRODUCT ADMINISTERED 49
612 EATING DISORDER 48
613 FEAR 48
614 MOOD SWINGS 48
615 PHARYNGITIS STREPTOCOCCAL 48
616 PHOTOPHOBIA 48
617 UNEVALUABLE EVENT 48
618 VITAMIN B12 INCREASED 48
619 ANKLE ARTHROPLASTY 47
620 BLOOD PRESSURE SYSTOLIC ABNORMAL 47
621 PROCTALGIA 47
622 PRODUCT PRESCRIBING ERROR 47
623 PULMONARY OEDEMA 47
624 SENSORY DISTURBANCE 47
625 URINE LEUKOCYTE ESTERASE POSITIVE 47
626 ABDOMINAL PAIN LOWER 46
627 ASPARTATE AMINOTRANSFERASE ABNORMAL 46
628 DEEP VEIN THROMBOSIS 46
629 DERMATITIS ALLERGIC 46
630 PALLOR 46
631 RESPIRATORY SYMPTOM 46
632 HEPATIC CYTOLYSIS 45
633 INFUSION SITE PRURITUS 45
634 INJECTION SITE MASS 45
635 LOCALISED INFECTION 45
636 PERFUME SENSITIVITY 45
637 SINUS TACHYCARDIA 45
638 SKIN INFECTION 45
639 BREAST CANCER STAGE I 44
640 BREATH SOUNDS ABNORMAL 44
641 ELECTROCARDIOGRAM QT PROLONGED 44
642 HYPOACUSIS 44
643 SKIN WARM 44
644 STEVENS-JOHNSON SYNDROME 44
645 DYSKINESIA 43
646 GASTROINTESTINAL HAEMORRHAGE 43
647 HYPERKALAEMIA 43
648 MOUTH SWELLING 43
649 PANCYTOPENIA 43
650 PSYCHOMOTOR HYPERACTIVITY 43
651 BRONCHIAL DISORDER 42
652 FEEDING DISORDER 42
653 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 42
654 PRE-EXISTING CONDITION IMPROVED 42
655 SCAR 42
656 THINKING ABNORMAL 42
657 GASTRITIS 41
658 HEPATOTOXICITY 41
659 HYPOKINESIA 41
660 INFUSION SITE ERYTHEMA 41
661 INJECTION SITE URTICARIA 41
662 MALIGNANT NEOPLASM PROGRESSION 41
663 PARANOIA 41
664 AFFECTIVE DISORDER 40
665 HEPATIC STEATOSIS 40
666 LIGAMENT SPRAIN 40
667 LYMPHOCYTE PERCENTAGE DECREASED 40
668 ORAL PRURITUS 40
669 PLATELET COUNT INCREASED 40
670 RESPIRATORY RATE INCREASED 40
671 SARS-COV-2 TEST NEGATIVE 40
672 SOMNAMBULISM 40
673 TENDERNESS 40
674 THIRST 40
675 TOXIC EPIDERMAL NECROLYSIS 40
676 URINE ANALYSIS ABNORMAL 40
677 ABNORMAL DREAMS 39
678 ARRHYTHMIA 39
679 DISEASE PROGRESSION 39
680 FLANK PAIN 39
681 FRUSTRATION TOLERANCE DECREASED 39
682 MOUTH ULCERATION 39
683 NEUTROPHIL PERCENTAGE INCREASED 39
684 PHARYNGEAL OEDEMA 39
685 PIGMENTATION DISORDER 39
686 RESTRICTIVE PULMONARY DISEASE 39
687 STAPHYLOCOCCAL INFECTION 39
688 ANAL INFLAMMATION 38
689 APHASIA 38
690 CHROMATURIA 38
691 END STAGE RENAL DISEASE 38
692 HAEMATOMA 38
693 INFUSION SITE SWELLING 38
694 NEOPLASM MALIGNANT 38
695 QUALITY OF LIFE DECREASED 38
696 ABSCESS 37
697 BACTERIAL TEST POSITIVE 37
698 CHOLELITHIASIS 37
699 GOUT 37
700 LYMPHOPENIA 37
701 MEAN CELL HAEMOGLOBIN DECREASED 37
702 PNEUMONIA ASPIRATION 37
703 POISONING 37
704 UPPER-AIRWAY COUGH SYNDROME 37
705 BLOOD PRESSURE ABNORMAL 36
706 CLOSTRIDIUM DIFFICILE INFECTION 36
707 ERYTHEMA MULTIFORME 36
708 FOOD INTOLERANCE 36
709 INFUSION SITE EXTRAVASATION 36
710 INSURANCE ISSUE 36
711 MASS 36
712 RIB FRACTURE 36
713 TOOTH FRACTURE 36
714 BRONCHIECTASIS 35
715 CARDIO-RESPIRATORY ARREST 35
716 DRUG ERUPTION 35
717 DRY THROAT 35
718 JAUNDICE 35
719 PARANASAL SINUS DISCOMFORT 35
720 RESPIRATORY SYNCYTIAL VIRUS INFECTION 35
721 SINUS HEADACHE 35
722 TOOTH DISORDER 35
723 TOOTH INFECTION 35
724 CORONARY ARTERY DISEASE 34
725 DYSSTASIA 34
726 INFUSION SITE DISCHARGE 34
727 MICTURITION URGENCY 34
728 NEEDLE ISSUE 34
729 SYNOVIAL CYST 34
730 CHOLESTASIS 33
731 GLOMERULAR FILTRATION RATE DECREASED 33
732 HYPOMAGNESAEMIA 33
733 MASTOCYTOSIS 33
734 ORAL PAIN 33
735 PARKINSON^S DISEASE 33
736 SCAB 33
737 SENSATION OF FOREIGN BODY 33
738 URTICARIA THERMAL 33
739 ALTERED STATE OF CONSCIOUSNESS 32
740 BLOOD SODIUM DECREASED 32
741 CANDIDA INFECTION 32
742 DEPRESSED LEVEL OF CONSCIOUSNESS 32
743 DIZZINESS POSTURAL 32
744 GRANULOMA 32
745 HYPERGLYCAEMIA 32
746 INJECTION SITE RASH 32
747 MYDRIASIS 32
748 NEPHROGENIC ANAEMIA 32
749 PANCREATITIS ACUTE 32
750 PARALYSIS 32
751 PRODUCT ADMINISTRATION ERROR 32
752 ROTATOR CUFF SYNDROME 32
753 STREPTOCOCCAL INFECTION 32
754 TACHYPNOEA 32
755 UPPER LIMB FRACTURE 32
756 URTICARIA CHRONIC 32
757 VICTIM OF CHEMICAL SUBMISSION 32
758 HEPATIC FUNCTION ABNORMAL 31
759 IMPAIRED QUALITY OF LIFE 31
760 MAST CELL ACTIVATION SYNDROME 31
761 NASAL DRYNESS 31
762 NERVE COMPRESSION 31
763 PAIN IN JAW 31
764 RHONCHI 31
765 SENSORY LOSS 31
766 SKIN ABRASION 31
767 TOOTH ABSCESS 31
768 TOOTHACHE 31
769 TUBULOINTERSTITIAL NEPHRITIS 31
770 ABDOMINAL TENDERNESS 30
771 ABNORMAL BEHAVIOUR 30
772 ANXIETY DISORDER 30
773 APHTHOUS ULCER 30
774 BRONCHIAL NEOPLASM 30
775 COVID-19 PNEUMONIA 30
776 ENDOMETRIAL ABLATION 30
777 EYE INFLAMMATION 30
778 GASTRIC DISORDER 30
779 GLAUCOMA 30
780 HEPATOCELLULAR INJURY 30
781 HYPOAESTHESIA ORAL 30
782 RED CELL DISTRIBUTION WIDTH INCREASED 30
783 SINUS PAIN 30
784 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 30
785 THYROID DISORDER 30
786 ATELECTASIS 29
787 BRONCHIAL HAEMORRHAGE 29
788 DERMATITIS 29
789 ERECTILE DYSFUNCTION 29
790 FOOD POISONING 29
791 IMPAIRED GASTRIC EMPTYING 29
792 INFUSION SITE HAEMORRHAGE 29
793 LIVER FUNCTION TEST ABNORMAL 29
794 NASAL TURBINATE HYPERTROPHY 29
795 RED CELL DISTRIBUTION WIDTH DECREASED 29
796 TARDIVE DYSKINESIA 29
797 TENDONITIS 29
798 VAGINAL HAEMORRHAGE 29
799 WRIST FRACTURE 29
800 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 28
801 ALLERGIC REACTION TO EXCIPIENT 28
802 ATTENTION DEFICIT HYPERACTIVITY DISORDER 28
803 BACTERIAL INFECTION 28
804 BLOOD THYROID STIMULATING HORMONE INCREASED 28
805 BREAST CANCER 28
806 IRON DEFICIENCY ANAEMIA 28
807 LUNG NEOPLASM MALIGNANT 28
808 PETECHIAE 28
809 PULMONARY CONGESTION 28
810 RED BLOOD CELLS URINE POSITIVE 28
811 SKIN ULCER 28
812 THERAPY CESSATION 28
813 ALLERGY TO ANIMAL 27
814 ANGINA PECTORIS 27
815 BONE LOSS 27
816 DECREASED ACTIVITY 27
817 EAR DISCOMFORT 27
818 EAR PRURITUS 27
819 EWING^S SARCOMA 27
820 EYE DISCHARGE 27
821 GENERALISED OEDEMA 27
822 IMMUNE THROMBOCYTOPENIA 27
823 INCREASED APPETITE 27
824 INFLAMMATORY BOWEL DISEASE 27
825 NERVOUS SYSTEM DISORDER 27
826 SKIN FISSURES 27
827 URINARY SEDIMENT PRESENT 27
828 WRONG DRUG ADMINISTERED 27
829 ACUTE RESPIRATORY FAILURE 26
830 BLOOD BILIRUBIN INCREASED 26
831 BLOOD IRON DECREASED 26
832 CONCUSSION 26
833 CONVULSION 26
834 CRYSTAL URINE PRESENT 26
835 DEFORMITY 26
836 DEVICE ISSUE 26
837 DYSLIPIDAEMIA 26
838 EMOTIONAL DISORDER 26
839 GALLBLADDER DISORDER 26
840 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26
841 IMPAIRED WORK ABILITY 26
842 INJECTION SITE WARMTH 26
843 NASAL POLYPS 26
844 POSTOPERATIVE WOUND INFECTION 26
845 PSYCHOTIC DISORDER 26
846 PULMONARY MASS 26
847 PURPURA 26
848 TONGUE OEDEMA 26
849 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 25
850 ASPARTATE AMINOTRANSFERASE 25
851 DYSPHEMIA 25
852 GLOSSITIS 25
853 HAEMATURIA 25
854 HALLUCINATION, VISUAL 25
855 LACTIC ACIDOSIS 25
856 PAROSMIA 25
857 SLUGGISHNESS 25
858 TENDON DISORDER 25
859 THERAPEUTIC PRODUCT EFFECT DELAYED 25
860 UNRESPONSIVE TO STIMULI 25
861 VITAMIN B12 DECREASED 25
862 BASAL CELL CARCINOMA 24
863 DRUG DOSE OMISSION 24
864 DRUG LEVEL INCREASED 24
865 HEPATIC ENZYME ABNORMAL 24
866 HIP FRACTURE 24
867 IMMUNE SYSTEM DISORDER 24
868 INCORRECT DRUG ADMINISTRATION RATE 24
869 INJECTION SITE IRRITATION 24
870 INTENTIONAL SELF-INJURY 24
871 LOWER RESPIRATORY TRACT CONGESTION 24
872 MANIA 24
873 PULMONARY FUNCTION TEST DECREASED 24
874 PULMONARY PAIN 24
875 ROSACEA 24
876 SENSITIVE SKIN 24
877 SJOGREN^S SYNDROME 24
878 SKIN SWELLING 24
879 TRANSAMINASES INCREASED 24
880 VITAL CAPACITY DECREASED 24
881 BLOOD COUNT ABNORMAL 23
882 BREAST MASS 23
883 CARDIOMEGALY 23
884 CARPAL TUNNEL SYNDROME 23
885 COLD SWEAT 23
886 DEAFNESS 23
887 EAR SWELLING 23
888 EXPOSURE TO TOXIC AGENT 23
889 HEPATIC FAILURE 23
890 HIATUS HERNIA 23
891 INFUSION SITE BRUISING 23
892 MATERNAL EXPOSURE DURING BREAST FEEDING 23
893 PERIPHERAL COLDNESS 23
894 RENAL INJURY 23
895 RHABDOMYOLYSIS 23
896 SEROTONIN SYNDROME 23
897 VASCULAR ACCESS COMPLICATION 23
898 WOUND COMPLICATION 23
899 ABNORMAL WEIGHT GAIN 22
900 AGRANULOCYTOSIS 22
901 ALPHA TUMOUR NECROSIS FACTOR INCREASED 22
902 BONE DENSITY DECREASED 22
903 CYST 22
904 DERMATITIS EXFOLIATIVE 22
905 DUST ALLERGY 22
906 ENCEPHALOPATHY 22
907 GASTROINTESTINAL PAIN 22
908 GENERALISED TONIC-CLONIC SEIZURE 22
909 HEPATITIS ACUTE 22
910 HYPERVENTILATION 22
911 INJECTION SITE INFLAMMATION 22
912 INTERLEUKIN LEVEL INCREASED 22
913 MEAN CELL VOLUME DECREASED 22
914 MONOCYTE CHEMOTACTIC PROTEIN-1 INCREASED 22
915 MUCOSAL INFLAMMATION 22
916 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22
917 MUSCULOSKELETAL DISORDER 22
918 OCULAR DISCOMFORT 22
919 PHARYNGEAL PARAESTHESIA 22
920 POLYCYSTIC OVARIES 22
921 RESPIRATION ABNORMAL 22
922 SKIN LACERATION 22
923 SKIN MASS 22
924 ABNORMAL FAECES 21
925 BRAIN OEDEMA 21
926 BRUXISM 21
927 CHOLECYSTITIS 21
928 COMPLICATION ASSOCIATED WITH DEVICE 21
929 DEMENTIA 21
930 DYSTONIA 21
931 ERUCTATION 21
932 EYE INFECTION 21
933 HEART RATE ABNORMAL 21
934 HEMIPARESIS 21
935 MUSCULOSKELETAL CHEST PAIN 21
936 NASAL DISCHARGE DISCOLOURATION 21
937 PLASMA CELL MYELOMA 21
938 POISONING DELIBERATE 21
939 PRODUCT STORAGE ERROR 21
940 PRURITUS ALLERGIC 21
941 RALES 21
942 RESPIRATORY DISTRESS 21
943 SPINAL FRACTURE 21
944 TENDER JOINT COUNT 21
945 THERAPEUTIC PRODUCT EFFECT VARIABLE 21
946 TONGUE DISCOLOURATION 21
947 ANKYLOSING SPONDYLITIS 20
948 BREAST PAIN 20
949 CHOKING SENSATION 20
950 DELUSION 20
951 DIABETES MELLITUS INADEQUATE CONTROL 20
952 EYE OEDEMA 20
953 FAECES DISCOLOURED 20
954 FEAR OF INJECTION 20
955 FEELING DRUNK 20
956 FORMICATION 20
957 HYPER IGE SYNDROME 20
958 HYPERTHYROIDISM 20
959 INJECTION SITE DISCOMFORT 20
960 INTERVERTEBRAL DISC DEGENERATION 20
961 JOINT ARTHROPLASTY 20
962 MALIGNANT MELANOMA 20
963 MEAN PLATELET VOLUME DECREASED 20
964 MUSCULOSKELETAL DEFORMITY 20
965 OBSTRUCTION 20
966 OSTEOPENIA 20
967 PHYSICAL DISABILITY 20
968 PRODUCT DISTRIBUTION ISSUE 20
969 PULMONARY THROMBOSIS 20
970 RED BLOOD CELL SEDIMENTATION RATE 20
971 TOXIC SKIN ERUPTION 20
972 UROSEPSIS 20
973 BLOOD POTASSIUM INCREASED 19
974 BOWEL MOVEMENT IRREGULARITY 19
975 DUODENAL ULCER 19
976 ELECTRIC SHOCK SENSATION 19
977 FEELING OF BODY TEMPERATURE CHANGE 19
978 GASTRIC ULCER 19
979 GASTROINTESTINAL INFECTION 19
980 GLUCOSE TOLERANCE IMPAIRED 19
981 HUNGER 19
982 HYPERTHERMIA 19
983 HYPOPHAGIA 19
984 IMMUNISATION REACTION 19
985 INCONTINENCE 19
986 MENSTRUATION IRREGULAR 19
987 ORAL DISORDER 19
988 PERFORATION 19
989 PORTAL VEIN THROMBOSIS 19
990 POST PROCEDURAL INFECTION 19
991 PSEUDOMONAS INFECTION 19
992 REBOUND EFFECT 19
993 SKIN CANCER 19
994 SOCIAL PROBLEM 19
995 SWELLING OF EYELID 19
996 TRYPTASE INCREASED 19
997 VASCULAR DEVICE INFECTION 19
998 ANAL INCONTINENCE 18
999 APPETITE DISORDER 18